World's Best Scientists 2026 revealed!
Award Badge
Best Scientists
2025
Award Badge
Immunology
USA
2026

D-Index & Metrics

Best Scientists

D-Index
204
Citations
169161
World Ranking
248
National Ranking
164

Immunology

D-Index
203
Citations
168976
World Ranking
9
National Ranking
5

Medicine

D-Index
204
Citations
170365
World Ranking
157
National Ranking
106

Robert C. Gallo publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Robert C. Gallo sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 1,133 publications — 100th percentile

100% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Robert C. Gallo D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Robert C. Gallo sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 203 D-Index — 100th percentile

100% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Immunology in United States Leader Award
  • 2026 - Research.com Medicine in United States Leader Award
  • 2025 - Research.com Best Scientists Award
  • 2025 - Research.com Immunology in United States Leader Award
  • 2025 - Research.com Medicine in United States Leader Award
  • 2012 - Fellow, National Academy of Inventors
  • 2005 - Fellow of the American Association for the Advancement of Science (AAAS)
  • 1999 - Paul Ehrlich and Ludwig Darmstaedter Prize
  • 1997 - Warren Alpert Foundation Prize For their discovery of human immune deficiency virus (HIV).
  • 1990 - Karl Landsteiner Memorial Award, American Association of Blood Banks (AABB)
  • 1989 - Member of the National Academy of Medicine (NAM)
  • 1988 - Japan Prize for the discovery of the AIDS-causing virus and development of diagnostic methods.
  • 1988 - Member of the National Academy of Sciences
  • 1987 - Canada Gairdner International Award
  • 1985 - Society Citation Award, Infectious Diseases Society of America
  • 1984 - Charles S. Mott Prize, General Motors Cancer Research Foundation
  • 1982 - Albert Lasker Award for Basic Medical Research, Lasker Foundation
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Robert C. Gallo is affiliated with the University of South Florida in the United States. Their research spans several areas within medicine and immunology, particularly focusing on infectious diseases and virology.

The main fields of study include:

  • Medicine
  • Immunology and Microbiology

Within these domains, subfields of their work encompass:

  • Immunology
  • Infectious Diseases
  • Virology
  • Molecular Biology
  • Ecology

The primary research topics addressed in their publications are:

  • SARS-CoV-2 and COVID-19 Research
  • HIV Research and Treatment
  • Immune responses and vaccinations
  • Bacteriophages and microbial interactions
  • Microbial infections and disease research
  • Immune Cell Function and Interaction
  • Viral gastroenteritis research and epidemiology

Frequently publishing in specific venues, Robert C. Gallo has contributed multiple works to:

  • Journal of Translational Medicine
  • Proceedings of the National Academy of Sciences
  • Cell Host & Microbe
  • International Journal of Molecular Sciences
  • Vaccine

Some of the recent papers authored or coauthored include:

  • Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant, 2020, Journal of Translational Medicine
  • Can existing live vaccines prevent COVID-19?, 2020, Science
  • Old vaccines for new infections: Exploiting innate immunity to control COVID-19 and prevent future pandemics, 2021, Proceedings of the National Academy of Sciences
  • Covid-19: Time for a paradigm change, 2020, Reviews in Medical Virology
  • Emerging of a SARS-CoV-2 viral strain with a deletion in nsp1, 2020, Journal of Translational Medicine

Regular collaborators in research efforts include:

  • Davide Zella
  • Francesca Benedetti
  • Konstantin Chumakov
  • Mohammad M. Sajadi
  • Shyamasundaran Kottilil

Throughout their career, Robert C. Gallo has received several awards, such as:

  • Fellow, National Academy of Inventors (2012)
  • Fellow of the American Association for the Advancement of Science (AAAS) (2005)
  • Paul Ehrlich and Ludwig Darmstaedter Prize (1999)
  • Warren Alpert Foundation Prize (1997) - For the discovery of human immune deficiency virus (HIV)
  • Karl Landsteiner Memorial Award, American Association of Blood Banks (AABB) (1990)
  • Member of the National Academy of Medicine (NAM) (1989)
  • Japan Prize (1988) - For the discovery of the AIDS-causing virus and development of diagnostic methods
  • Member of the National Academy of Sciences (1988)
  • Canada Gairdner International Award (1987)
  • Society Citation Award, Infectious Diseases Society of America (1985)
  • Charles S. Mott Prize, General Motors Cancer Research Foundation (1984)
  • Albert Lasker Award for Basic Medical Research, Lasker Foundation (1982)
  • Member of the Association of American Physicians

Best Publications

  • Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma

    Bernard J. Poiesz;Francis W. Ruscetti;Adi F. Gazdar;Paul A. Bunn

  • Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS

    Robert C. Gallo;Syed Z. Salahuddin;Mikulas Popovic;Gene M. Shearer

  • Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS

    Mikulas Popovic;M. G. Sarngadharan;Elizabeth Read;Robert C. Gallo

  • Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells

    Fiorenza Cocchi;Anthony L. DeVico;Alfredo Garzino-Demo;Suresh K. Arya

  • Selective in vitro growth of T lymphocytes from normal human bone marrows

    Doris Anne Morgan;Francis W. Ruscetti;Robert Gallo

  • Complete nucleotide sequence of the AIDS virus, HTLV-III

    Lee Ratner;William Haseltine;Roberto Patarca;Kenneth J. Livak

  • Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture.

    Steven J. Collins;Robert C. Gallo;Robert E. Gallagher

  • 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.

    H Mitsuya;K J Weinhold;P A Furman;M H St Clair

  • The role of mononuclear phagocytes in HTLV-III/LAV infection

    Suzanne Gartner;Paul Markovits;David M. Markovitz;Mark H. Kaplan

  • Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells

    Riccardo dalla-Favera;Marco Bregni;Jan Erikson;David Patterson

  • Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds.

    Steven J. Collins;Francis W. Ruscetti;Robert E. Gallagher;Robert C. Gallo

  • Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS)

    Robert C. Gallo;Prem S. Sarin;E. P. Gelmann;Marjorie Robert-Guroff

  • Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders

    SZ Salahuddin;DV Ablashi;PD Markham;SF Josephs

  • Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS

    M. G. Sarngadharan;Mikulas Popovic;Lilian Bruch;Jörg Schüpbach

  • A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia

    VS Kalyanaraman;MG Sarngadharan;M Robert-Guroff;I Miyoshi

  • Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia

    R Gallagher;S Collins;J Trujillo;K McCredie

  • HTLV-III infection in brains of children and adults with AIDS encephalopathy

    George M. Shaw;Mary E. Harper;Beatrice H. Hahn;Leon G. Epstein

  • Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients

    B Ensoli;G Barillari;S Z Salahuddin;R C Gallo

  • Isolation of a new type C retrovirus (HTLV) in primary uncultured cells of a patient with Sézary T-cell leukaemia.

    Bernard J. Poiesz;Francis W. Ruscetti;Marvin S. Reitz;V. S. Kalyanaraman

  • ADMINISTRATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE, AN INHIBITOR OF HTLV-III/LAV REPLICATION, TO PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX

    Robert Yarchoan;Kent J. Weinhold;H. Kim Lyerly;Edward Gelmann

  • Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant.

    Maria Pachetti;Maria Pachetti;Bruna Marini;Francesca Benedetti;Fabiola Giudici

Frequent Co-Authors

Marvin S. Reitz
Marvin S. Reitz University of Maryland, Baltimore
Marjorie Robert-Guroff
Marjorie Robert-Guroff National Institutes of Health
Mikulas Popovic
Mikulas Popovic University of Maryland, Baltimore
M. G. Sarngadharan
M. G. Sarngadharan AkzoNobel (Netherlands)
Genoveffa Franchini
Genoveffa Franchini National Institutes of Health
Anthony L. DeVico
Anthony L. DeVico University of Maryland, Baltimore
Barbara Ensoli
Barbara Ensoli Istituto Superiore di Sanità
Phillip D. Markham
Phillip D. Markham Northrop Grumman (United States)
Paolo Lusso
Paolo Lusso National Institutes of Health
William A. Blattner
William A. Blattner University of Maryland, Baltimore

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career opportunities. Many professionals transition into specialized fields by starting with foundational nursing education. Online programs offer flexible options, especially for individuals without prior nursing experience. For example, online BSN programs for non nurses provide accessible pathways to become registered nurses through virtual coursework and clinical placements.

Accelerated options are also popular for those seeking quicker entry into nursing. Resources like accelerated BSN programs for non nurses highlight programs with less stringent admissions, enabling faster progress toward a nursing career.

Additionally, becoming a Licensed Practical Nurse (LPN) can serve as an entry point to more advanced roles. Guides to LPN schools easy to get into help prospective students find accessible programs that provide practical skills in patient care.

For those aiming to advance their clinical expertise, easy nurse practitioner programs to get into offer crucial training to become advanced practice nurses, often in specialties closely aligned with immunology and healthcare research.

Best Scientists Citing Robert C. Gallo

Trending Scientists

Recently Published Articles